Roche-HIV.com
 
  Home | Disclaimer | Sitemap | Glossary | Library cart | Useful links | Keep me informed | Roche worldwide | Contact webmaster  
  
   Search this site
  Roche in HIV
  Understanding HIV
 
  About HIV
 
  Management issues
 
  Resistance
  Adherence
 
  Guidelines (HIV and HCV)
  Pharmaceutical products  
  Commitment to research  
  Commitment to access  
  Conferences  
  News and features
  Healthcare professionals

How are pharmacokinetics measured

Following multiple dosing over several days of treatment, the maximum and minimum concentrations of drug achieved after each dose reach constant levels. This is termed the �steady-state�. Steady-state pharmacokinetics are generally described using five parameters (Figure 1).

Figure 1. Drug concentration over time. Defining pharmacokinetic parameters.

Cmax: peak plasma concentration

  • Cmax is the highest observed plasma concentration achieved during a dosing interval

Tmax: time to reach Cmax

  • Tmax is the time taken to reach the highest observed plasma concentration

Cmin: minimum (trough) plasma concentration

  • Cmin is the lowest observed plasma concentration achieved during a dosing interval. Cmin is also called the �trough concentration�

AUC: area under the curve

  • AUC is the total plasma exposure achieved during a certain time period. After repeated dosing, it is often expressed as the plasma exposure over a 24-hour period (AUC0�24). AUC is derived from the area under the plasma concentration versus time curve (shaded area in Figure 1)

T1/2: half-life

  • This is the time taken for the plasma levels of drug to fall by 50%. Drugs with a short half-life are eliminated rapidly from the body; those with a long half-life remain in the body for a longer period of time. If a PI has a long half-life, or if the half-life can be extended, there is the potential for less frequent dosing (e.g. twice- or even once-daily)
« Back Next »
Home | Disclaimer | Sitemap | Glossary | Library cart | Useful links | Keep me informed | Roche worldwide
All information contained in this website is generated and maintained by F. Hoffmann-La Roche, Ltd, Basel, Switzerland. This site is intended for use by physicians only. This site is not intended for residents of the United States of America.
Copyright 2006 F. Hoffmann La Roche Ltd.
Contact webmaster